Investigating how genetics and ancestry affect asthma and COPD treatment responses
Effects of Rare Variants and Ancestry on Beta Agonist Response in Asthma and COPD
This study is looking at how your unique genes and background might affect how well asthma and COPD medications work for you, and it invites patients to share their genetic information to help find out more about this connection.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Mayo Clinic Arizona NIH-funded |
| Lab location | 1 site (Scottsdale, United States) |
| Project ID | NIH-10620284 on NIH RePORTER |
What this research studies
This research explores the impact of rare genetic variants and ancestry on how patients with asthma and COPD respond to beta agonist medications. By analyzing genetic data from diverse patient groups, the study aims to identify specific genetic factors that influence treatment effectiveness and lung function. The approach includes both conventional genetic analysis and functional assessments to understand the role of ancestry-specific variations. Patients may be asked to provide genetic samples and participate in assessments to help uncover these important relationships.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals with asthma or COPD, particularly those of African American descent or from diverse ethnic backgrounds.
Not a fit: Patients who do not have asthma or COPD, or those who do not have a genetic predisposition affecting their response to beta agonists may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more personalized and effective treatment strategies for asthma and COPD patients based on their genetic background.
How similar studies have performed: Previous research has indicated that genetic factors can significantly influence treatment responses in asthma and COPD, suggesting that this study's approach is grounded in established findings.
Where this research is happening
Scottsdale, United States
- Mayo Clinic Arizona — Scottsdale, United States (Active)
Researchers
- Principal investigator: Ortega, Victor E. — Mayo Clinic Arizona
- Study coordinator: Ortega, Victor E.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.